These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1858563)

  • 1. Molecular genetics of apoC-II and lipoprotein lipase deficiency.
    Fojo SS; de Gennes JL; Beisiegel U; Baggio G; Stalenhoef AF; Brunzell JD; Brewer HB
    Adv Exp Med Biol; 1991; 285():329-33. PubMed ID: 1858563
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
    Reina M; Brunzell JD; Deeb SS
    J Lipid Res; 1992 Dec; 33(12):1823-32. PubMed ID: 1479292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
    Parrott CL; Alsayed N; Rebourcet R; Santamarina-Fojo S
    J Lipid Res; 1992 Mar; 33(3):361-7. PubMed ID: 1569385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.
    Fojo SS; Brewer HB
    J Intern Med; 1992 Jun; 231(6):669-77. PubMed ID: 1619390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
    Stalenhoef AF; Casparie AF; Demacker PN; Stouten JT; Lutterman JA; van 't Laar A
    Metabolism; 1981 Sep; 30(9):919-26. PubMed ID: 7266379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chylomicronemia].
    Yamamoto T; Kawakami M
    Nihon Rinsho; 1990 Nov; 48(11):2526-31. PubMed ID: 2270016
    [No Abstract]   [Full Text] [Related]  

  • 8. The familial hyperchylomicronaemia syndrome.
    Bijvoet SM; Bruin T; Kastelein JJ
    Neth J Med; 1993 Feb; 42(1-2):36-44. PubMed ID: 8446222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary hyperchylomicronemia and gene defects].
    Iwasaki M; Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2759-64. PubMed ID: 10638209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
    Hata A; Emi M; Luc G; Basdevant A; Gambert P; Iverius PH; Lalouel JM
    Am J Hum Genet; 1990 Oct; 47(4):721-6. PubMed ID: 2121025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy.
    Wilson CJ; Priore Oliva C; Maggi F; Catapano AL; Calandra S
    Ann Neurol; 2003 Jun; 53(6):807-10. PubMed ID: 12783430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new case of apo C-II deficiency with a nonsense mutation in the apo C-II gene.
    Zanelli T; Catapano AL; Averna MR; Barbagallo CM; Liotta A; Giardina FC; Notarbartolo A
    Clin Chim Acta; 1994 Jan; 224(2):111-8. PubMed ID: 8004780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.
    Sprecher DL; Taam L; Gregg RE; Fojo SS; Wilson DM; Kashyap ML; Brewer HB
    J Lipid Res; 1988 Mar; 29(3):273-8. PubMed ID: 3379339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the apoC-II gene in apoC-II deficient patients.
    Fojo SS; Law SW; Sprecher DL; Gregg RE; Baggio G; Brewer HB
    Biochem Biophys Res Commun; 1984 Oct; 124(1):308-13. PubMed ID: 6093789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II.
    Fojo SS; Stalenhoef AF; Marr K; Gregg RE; Ross RS; Brewer HB
    J Biol Chem; 1988 Dec; 263(34):17913-6. PubMed ID: 3192518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 18. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene.
    Takase S; Osuga J; Fujita H; Hara K; Sekiya M; Igarashi M; Takanashi M; Takeuchi Y; Izumida Y; Ohta K; Kumagai M; Nishi M; Kubota M; Masuda Y; Taira Y; Okazaki S; Iizuka Y; Yahagi N; Ohashi K; Yoshida H; Yanai H; Tada N; Gotoda T; Ishibashi S; Kadowaki T; Okazaki H
    J Atheroscler Thromb; 2013; 20(5):481-93. PubMed ID: 23470567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid restriction site screening method for the Pro207-->Leu mutation in the lipoprotein lipase gene.
    Lévesque G; Julien P; Deshaies Y; Lupien PJ; Ven Murthy MR
    Hum Mutat; 1994; 3(4):416-7. PubMed ID: 7915934
    [No Abstract]   [Full Text] [Related]  

  • 20. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
    J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.